Our client is a clinical-stage biotech company listed on Euronext and Nasdaq, focused on the development of innovative therapies and diagnostics for chronic and rare liver diseases. As part of a broad...
Our client is a clinical-stage biotech company listed on Euronext and Nasdaq, focused on the development of innovative therapies and diagnostics for chronic and rare liver diseases. As part of a broad...